Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jul;9(4):285-91.
doi: 10.1007/s11910-009-0043-4.

Paraneoplastic movement disorders

Affiliations
Review

Paraneoplastic movement disorders

Shyamal H Mehta et al. Curr Neurol Neurosci Rep. 2009 Jul.

Abstract

Neurologic paraneoplastic syndromes (NPSs) result from damage to the nervous system due to the remote effects of cancer not related to metastasis, infection, or metabolic derangements. NPSs are rare, affecting 1 in 10,000 patients with cancer. Pathogenesis is likely related to the immune mechanisms: normal neural tissue is mistakenly attacked due to the similarity in the onconeural antigens expressed by the tumor cells. Among the various "classic" and other NPSs, this review focuses on paraneoplastic movement disorders, including ataxia due to cerebellar degeneration, stiff-person syndrome, opsoclonus-myoclonus syndrome, chorea, parkinsonism, and tremor. The recently described syndrome of paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis is also included, given that these patients have complex movements such as stereotypies and dyskinesias in addition to psychiatric symptoms, altered sensorium, and other neurologic signs. Although variable, treatment and prognosis of NPSs rely heavily on treatment of the underlying malignancy and immunotherapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurology. 2008 Apr 8;70(15):1292-3 - PubMed
    1. J Pediatr Oncol Nurs. 2005 Jan-Feb;22(1):8-19 - PubMed
    1. Neuro Oncol. 2002 Jul;4(3):192-5 - PubMed
    1. Eur J Neurol. 2004 Feb;11(2):83-9 - PubMed
    1. Arch Neurol. 2001 Jul;58(7):1133-5 - PubMed

MeSH terms

Substances

LinkOut - more resources